EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Molecular pathophysiology of chronic kidney disease–mineral and bone disorder: Focus on the fibroblast growth factor 23–Klotho axis and bone turnover dynamics

Alief Waitupu, Laras Pratiwi, Henry Sutanto iD, Djoko Santoso, Decsa Medika Hertanto

Experimental Physiology · 2025-02-27

DOI: 10.1113/ep092401 ↗

At a glance

Übersichtsarbeit in Experimental Physiology, published online on 2025-02-27. Written by Alief Waitupu and 4 co-authors. Institution: Internal Medicine Study Program, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia. Cited 20 times so far (Crossref); 93 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Chronic kidney disease–mineral and bone disorder (CKD‐MBD) is a major complication of chronic kidney disease (CKD), characterized by disruptions in mineral metabolism, abnormal bone turnover and vascular calcification, which collectively increase the risk of fractures and cardiovascular disease. This review examines the molecular mechanisms underlying CKD‐MBD, with a particular focus on the fibroblast growth factor 23 (FGF23)–Klotho axis – a key regulator of phosphate balance, vitamin D activation and parathyroid hormone secretion. In CKD, elevated FGF23 levels and reduced Klotho expression contribute to mineral homeostasis disturbances and bone abnormalities. The dysregulation of this pathway plays a central role in CKD‐MBD pathophysiology and its associated complications. Emerging therapies, such as anti‐FGF23 antibodies and recombinant Klotho, hold promise for modulating FGF23 activity and restoring mineral balance. This review highlights the importance of individualized treatment strategies based on bone turnover patterns and FGF23–Klotho axis dysfunction. Advancing our understanding of these molecular mechanisms will aid in the development of more effective diagnostic tools and therapeutic interventions to improve CKD‐MBD outcomes.

Subjects

Author keywords

FGF23Klothobone turnoverchronic kidney diseasemineral and bone disorder

Authors and institutions

  • Internal Medicine Study Program, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
  • Department of Internal Medicine, Dr Soetomo General Academic Hospital, Surabaya, Indonesia.
  • Division of Nephrology and Hypertension, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.

ORCID profiles: Henry Sutanto

Cite

APA

Waitupu, A., Pratiwi, L., Sutanto, H., Santoso, D., & Hertanto, D. M. (2025). Molecular pathophysiology of chronic kidney disease–mineral and bone disorder: Focus on the fibroblast growth factor 23–Klotho axis and bone turnover dynamics. Experimental Physiology. https://doi.org/10.1113/ep092401

Vancouver

Waitupu A, Pratiwi L, Sutanto H, Santoso D, Hertanto DM. Molecular pathophysiology of chronic kidney disease–mineral and bone disorder: Focus on the fibroblast growth factor 23–Klotho axis and bone turnover dynamics. Experimental Physiology. 2025. doi:10.1113/ep092401

BibTeX
@article{Waitupu2025,
  author = {Waitupu, Alief and Pratiwi, Laras and Sutanto, Henry and Santoso, Djoko and Hertanto, Decsa Medika},
  title = {Molecular pathophysiology of chronic kidney disease–mineral and bone disorder: Focus on the fibroblast growth factor 23–Klotho axis and bone turnover dynamics},
  journal = {Experimental Physiology},
  year = {2025},
  doi = {10.1113/ep092401}
}
Start for free →